NCT01609608

Brief Summary

  1. 1.Aim: The aim of this trial was to determine whether whole-body vibration (WBV) induced via a non-invasive oscillation platform could improve symptoms and health-related quality of life (HRQOL) in patients with chronic functional constipation.
  2. 2.Methods: A single-blinded, randomized, control trial was performed in a single Hospital in Taiwan. Patients diagnosed with chronic functional constipation, as per the Rome III diagnostic criteria were included and randomized to either the WBV treatment or no treatment (control) group. The treatment group received six 15-minute sessions of WBV therapy over a two-week period. Patients received vibrations of 2 mm in amplitude at a frequency of 12 Hz. The primary outcome was assessed by the constipation severity instrument (CSI). The secondary outcome was improvements in HRQOL.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

May 28, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 1, 2012

Completed
Last Updated

June 1, 2012

Status Verified

May 1, 2012

Enrollment Period

1 year

First QC Date

May 28, 2012

Last Update Submit

May 30, 2012

Conditions

Outcome Measures

Primary Outcomes (1)

  • change from baseline in constipation severity instrument (CSI) at 2 weeks

    baseline (day 1), the completion of the trial (day 14)

Secondary Outcomes (1)

  • change from baseline in health-related quality of life (HRQOL) at 2 weeks

    baseline (day 1), the completion of the trial (day 14)

Study Arms (2)

vibration

EXPERIMENTAL
Procedure: whole body vibration

placebo

PLACEBO COMPARATOR
Procedure: whole body vibration

Interventions

to deliver mechanical oscillation to individuals at various frequencies, amplitudes, and accelerations for different durations. This technique has been applied for years to enhance strength, and improve bone mineral density and balance

placebovibration

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • met the Rome III criteria of constipation

You may not qualify if:

  • pregnant
  • cardiovascular disease
  • cerebrovascular disease
  • recently undergone major surgery
  • hypothyroidism
  • depressive disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhua Christian hospital

Changhua, Taiwan, 500, Taiwan

Location

Related Publications (2)

  • Prisby RD, Lafage-Proust MH, Malaval L, Belli A, Vico L. Effects of whole body vibration on the skeleton and other organ systems in man and animal models: what we know and what we need to know. Ageing Res Rev. 2008 Dec;7(4):319-29. doi: 10.1016/j.arr.2008.07.004. Epub 2008 Aug 12.

  • Wu TJ, Wei TS, Chou YH, Yang CP, Wu CL, Chen YC, Liu SY. Whole-body vibration for functional constipation: a single-centre, single-blinded, randomized controlled trial. Colorectal Dis. 2012 Nov;14(11):e779-85. doi: 10.1111/codi.12021.

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical doctor

Study Record Dates

First Submitted

May 28, 2012

First Posted

June 1, 2012

Study Start

October 1, 2009

Primary Completion

October 1, 2010

Study Completion

November 1, 2010

Last Updated

June 1, 2012

Record last verified: 2012-05

Locations